S-TRAC trial: Sensitivity analyses of disease-free survival (DFS).

被引：0
|
作者：
George, Daniel J.
Pantuck, Allan J.
Motzer, Robert J.
Ravaud, Alain
Escudier, Bernard
Staehler, Michael D.
Serfass, Lucile
Krishnaswami, Sriram
Casey, Michelle
Lechuga, Mariajose
Koch, Gary
Figlin, Robert A.
机构：
[1] Duke Univ, Duke Canc Inst, Durham, NC USA
[2] Univ Calif Los Angeles, Inst Urol Oncol, David Geffen Sch Med, Los Angeles, CA USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY USA
[4] Bordeaux Univ Hosp, Hop St Andre, Bordeaux, France
[5] Inst Gustave Roussy, Villejuif, France
[6] Ludwig Maximilians Univ Munchen, Univ Hosp Munich Grosshadern, Munich, Germany
[7] Pfizer Oncology Inc, Paris, France
[8] Pfizer, New York, NY USA
[9] Pfizer Inc, Collegeville, PA USA
[10] Pfizer Srl, Milan, Italy
[11] Univ North Carolina Chapel Hill, Chapel Hill, NC USA
[12] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.633
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
633
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Disease-free survival and the prognostic factors affecting disease-free survival in patients with medullary thyroid carcinoma: a multicenter cohort study
    Zuhur, Sayid Shafi
    Ozturk, Beyza Olcay
    Keskin, Umran
    Uysal, Serhat
    Hacioglu, Aysa
    Avci, Ugur
    Karsli, Seda
    Andac, Burak
    Ozbay, Umit Nur
    Kilinc, Faruk
    Erol, Selvinaz
    Catak, Merve
    Sodan, Hulyanur
    Pekkolay, Zafer
    Burhan, Sebnem
    Akbaba, Gulhan
    Ates, Coskun
    Yorulmaz, Goknur
    Tekin, Sakin
    Topcu, Birol
    Tuna, Mazhar Muslum
    Kadioglu, Pinar
    Gonen, Mustafa Sait
    Karaca, Zuleyha
    Ciftci, Sema
    Celik, Mehmet
    Guldiken, Sibel
    Tuzun, Dilek
    Altuntas, Yuksel
    Akturk, Mujde
    Niyazoglu, Mutlu
    Cinar, Nese
    Gul, Ozen Oz
    Kebapci, Medine Nur
    Akalin, Aysen
    Bayraktaroglu, Taner
    Elbuken, Gulsah
    ENDOCRINE, 2024, 85 (03) : 1300 - 1309
  • [32] Local Disease-Free Survival and Disease-Free Survival in Locally Advanced Cervical Cancer Diagnosed and Treated in Bihor County, Romania
    Molnar, Otto
    Mihutiu, Simona
    Ilea, Codrin D.
    Vesa, Alexandra
    Straciuc, Oreste M.
    Nemeth, Noemi
    Lazar, Liviu
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [33] DISEASE-FREE SURVIVAL (DFS) AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL (OS) IN ADULTS WITH RESECTABLE ESOPHAGEAL OR GASTROESOPHAGEAL JUNCTION CANCER: A CORRELATION META-ANALYSIS
    Leung, L.
    Kurt, M.
    Singh, P.
    Kim, I
    Donnellan, G.
    Kanters, S.
    VALUE IN HEALTH, 2021, 24 : S1 - S1
  • [34] Disease-free survival (DFS) as a predictor of overall survival (OS) in completely resected early stage non-small cell lung cancer (NSCLC)
    West, H.
    Hu, X.
    Burke, T.
    Walker, M. S.
    Wang, Y.
    Samkari, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S74 - S75
  • [35] S-TRAC: UNDERSTANDING THE ADVERSE EVENT (AE) EXPERIENCE IN THE ADJUVANT TRIAL OF SUNITINIB FOR HIGH RISK RENAL CELL CARCINOMA (RCC)
    Wood, Sarah Yenser
    Ryan, Joanne C.
    Clair, Andrew G.
    George, Daniel
    ONCOLOGY NURSING FORUM, 2018, 45 (02)
  • [36] Histopathologic characteristics and disease-free survival of mammary Paget disease
    Albarracin, C.
    Gullett, A.
    Prieto, V.
    Kelly, C.
    Duan, X.
    Bassett, R.
    Klein, K.
    Resetkova, E.
    Rosen, D. G.
    Wu, Y.
    Sneige, N.
    VIRCHOWS ARCHIV, 2011, 459 : S3 - S3
  • [37] A comparative analysis of clinicopathological characteristics and disease-free survival (DFS) outcomes in breast cancer patients: Mammograpghy vs symptomatic diagnosis.
    Karaca, Mustafa
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [38] Association between density of tumor infiltrating lymphocytes and disease-free survival (DFS) in patients with resected stage I-III colorectal cancer in the FACS randomized trial.
    Pugh, Sian Alexandra
    Moutasim, Karwan
    Jenkins, Nicholas Mark
    Shinkins, Bethany
    Thomas, Gareth
    Mant, David
    Primrose, John Neil
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [39] Impact of chemotherapy-induced ovarian failure (CIOF) on disease-free survival (DFS) and overall survival (OS) in young women with early breast cancer (EBC)
    Furlanetto, J.
    Nekljudova, V.
    Schneeweiss, A.
    Thode, C.
    Denkert, C.
    Untch, M.
    Bassy, M.
    Karn, T.
    Fasching, P. A.
    Stickeler, E.
    Schem, C.
    Marme, F.
    Grischke, E. -M.
    van Mackelenbergh, M.
    Strik, D.
    Schmatloch, S.
    Mueller, V.
    Loibl, S.
    ANNALS OF ONCOLOGY, 2019, 30 : 57 - +
  • [40] Impact of Chemotherapy-Induced Ovarian Failure (CIOF) on Disease-Free Survival (DFS) and Overall Survival (OS) in Young Women with Early Breast Cancer (EBC)
    Furlanetto, Jenny
    Nekljudova, Valentina
    Schneeweiss, Andreas
    Thode, Christian
    Denkert, Carsten
    Untch, Michael
    Bassy, Martina
    Karn, Thomas
    Fasching, Peter A.
    Stickeler, Elmar
    Schem, Christian
    Marme, Frederik
    Grischke, Eva-Maria
    van Mackelenbergh, Marion
    Strik, Dorninika
    Schmatloch, Sabine
    Mueller, Volkmar
    Loibl, Sibylle
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 6 - 6
12345